IL6 and chronic myelogenous leukemia, BCR-ABL1 positive: In a process mediated by IL-6 after exposure to CML cells, normal hematopoietic progenitor cells acquired the genetic signatures of the malignant cells, altering the differentiation, reducing the ability for self-renewal, and increasing the division of normal cells.